Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1069-66-5
Purity
95%
Sodium valproate is an HDAC inhibitor. It is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches.
Properties
Name
Sodium valproate
Smiles
[Na+].CCCC(CCC)C(=O)[O-]
Targets
Please log in to see this information
SDS
Leptilan | VPA | depakine | divalproex sodium | sodium 2-propylpentanoate | sodium valproate | valproate | valproate sodium | valproic acid sodium | valproic acid sodium salt
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$39
2 mg
$41
5 mg
$43
10 mg
$45
15 mg
$47
20 mg
$50
25 mg
$55
30 mg
$59
35 mg
$62
40 mg
$64
45 mg
$67
50 mg
$69
75 mg
$72
100 mg
$74
Quantity
1
Total amount
$ 43
Leptilan | VPA | depakine | divalproex sodium | sodium 2-propylpentanoate | sodium valproate | valproate | valproate sodium | valproic acid sodium | valproic acid sodium salt
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.